Showing results (931-940 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|April 6, 2010
hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cellsBo Zhao, Zhen Jun Wang, Bing Qiang Yi, et al.Cancer Biology & Therapy|July 20, 2011
Hyperspectral imaging: a non-invasive method of imaging melanoma lesions in a patient with stage IV melanoma, being treated with a RAF inhibitorDavid T Dicker, Nadia Kahn, Keith T Flaherty, et al.Cancer Biology & Therapy|March 28, 2008
Iron chelator-based amplification strategy for improved targeting of transferrin receptor with SPIOClare Y Zhang, Jing Lu, Andrew TsourkasCancer Biology & Therapy|August 6, 2005
Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapyPuja Pnwar, Normando Iznaga-Escobar, Pushpa Mishra, et al.Cancer Biology & Therapy|June 22, 2026
KIF18A inhibitor prevents chromosomally unstable osteosarcoma growth by activating spindle assembly checkpointQiang Yan, Yan Zhang, Pengfei Wang, et al.Cancer Biology & Therapy|July 2, 2026
Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptidesBernardo Chavez, Vitali Sikirzhytski, Chang-Uk Lim, et al.Cancer Biology & Therapy|June 19, 2026
Opsonization and timing as key determinants of MBTA immunotherapy efficacy in pancreatic adenocarcinoma and recurrence treatmentAndrea Frejlachova, Radka Lencova, Ondrej Uher, et al.Cancer Biology & Therapy|June 23, 2026
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude versus low-altitude regions: a multi-center retrospective studyYujing Tan, Yinyin Ye, Weihong Zhao, et al.Cancer Biology & Therapy|June 26, 2026
ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinomaLinpei Wang, Jiawei Wang, Xiaoqiu Ma, et al.Cancer Biology & Therapy|July 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatinJolanta Kryczka, Jakub Mateusz Kryczka, Łukasz Janczewski, et al.Pageof 387